Free Trial

Nuvectis Pharma (NVCT) SEC Filings & 10K Form

Nuvectis Pharma logo
$7.47
-0.42 (-5.32%)
(As of 10/31/2024 ET)

Recent Nuvectis Pharma SEC Filings

DateFilerForm TypeView
08/29/2024
7:52 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
3:09 PM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
8:16 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
7:47 AM
Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
7:49 AM
Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
7:51 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:13 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:00 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:20 PM
Nuvectis Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:17 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
7:37 AM
Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
Form SC 13G/A
02/06/2024
7:47 AM
Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
Form SC 13G
01/30/2024
8:01 PM
Nuvectis Pharma (Subject)
Peters Thomas Phineas (Filed by)
Form SC 13G/A
01/05/2024
3:30 PM
Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:31 PM
Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:39 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
6:45 AM
Nuvectis Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVCT) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners